Effects of lipopolysaccharides of Bacterium prodigiosum on tumor growth and immunosuppression in mice.
- Author:
Chuan-lin YU
1
;
Zheng-guang ZHU
;
Lin-sheng LEI
;
Hua-lei CHANG
;
Hui-ling GAO
;
Na-na CHEN
;
Xian-guo YANG
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Antineoplastic Agents; pharmacology; Female; Immunosuppressive Agents; pharmacology; Lipopolysaccharides; isolation & purification; pharmacology; Male; Mice; Polysaccharides, Bacterial; isolation & purification; pharmacology; Random Allocation; Serratia; chemistry
- From: Journal of Southern Medical University 2009;29(10):2133-2137
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effects of lipopolysaccharides of Bacterium prodigiosum (BP-LPS) in inhibiting tumor growth and improving immunosuppression in mice.
METHODSIn mice bearing S180 tumor and a mouse model of immunosuppression induced by cyclophosphamide (CTX), the tumor growth, indexes of the immune organs and peripheral white blood cell count were measured after intraperitoneal injection of BP-LPS.
RESULTSInjections of BP-LPS (40 U/kg) for 8 consecutive days resulted in a significant inhibition of the tumor growth in mice bearing S180 tumor (P<0.01), with a dose-dependent increase of the spleen indexes but no obvious changes in the thymus indexes. Intraperitoneal injections of BP-LPS for 7 days inhibited the reduction of peripheral white blood cells and spleen indexes in immunosuppressive mice, but did not produce any significant changes in normal mice.
CONCLUSIONBP-LPS can inhibit the tumor growth in tumor-bearing mice and enhance the immune functions of immunosuppressive mice.